IXICO plc
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHYOF research report →
Companyixico.com
IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, Netherlands, Ireland, rest of Europe, the United States, and internationally. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.
- CEO
- Bram Goorden
- IPO
- 1997
- Employees
- 81
- HQ
- London, GB
Price Chart
Valuation
- Market Cap
- $6.52M
- P/E
- -4.77
- P/S
- 1.21
- P/B
- 0.67
- EV/EBITDA
- -2.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 47.28%
- Op Margin
- -34.93%
- Net Margin
- -25.27%
- ROE
- -13.74%
- ROIC
- -12.89%
Growth & Income
- Revenue
- $6.53M · 13.32%
- Net Income
- $-1,651,000 · 17.49%
- EPS
- $-0.02 · 55.31%
- Op Income
- $-2,554,000
- FCF YoY
- 14.80%
Performance & Tape
- 52W High
- $0.15
- 52W Low
- $0.07
- 50D MA
- $0.07
- 200D MA
- $0.07
- Beta
- 0.07
- Avg Volume
- 429.719
Get TickerSpark's AI analysis on PHYOF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our PHYOF Coverage
We haven't published any research on PHYOF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PHYOF Report →